Tirzepatide is the active drug in Mounjaro and Zepbound. It is a different molecule from semaglutide, the drug in Ozempic and Wegovy, and it behaves differently when it comes to allergic reactions.
Most of what is written about GLP-1 reactions treats the whole class as one thing. That matters if you have reacted to one of these medications and want to know what your options are.
How common are tirzepatide reactions?
In the pooled placebo-controlled trials, hypersensitivity reactions were reported in 3.2% of adults taking Mounjaro, compared with 1.7% of adults taking placebo. The label describes these as sometimes severe and gives urticaria and eczema as examples. The reaction rate attributable to the drug is therefore closer to one and a half percentage points than to the headline 3.2%, because a share of people report skin symptoms during any trial regardless of what they were given.
Patients who develop antibodies to tirzepatide report hypersensitivity reactions somewhat more often, at 4.1% against 3.0% in those who do not. The difference is modest, though it does point toward an immune-mediated process in at least some cases.
Injection site reactions are counted separately and were reported in 3.2% of Mounjaro-treated patients against 0.4% on placebo. That gap is much wider, which makes local reactions the more clearly drug-related of the two, and also the less serious, since they stay where the needle went in.
Gastrointestinal side effects remain by far the most frequent problem with tirzepatide. Nausea, vomiting and diarrhea are not allergic reactions and are not what this page is about.
A reaction can start after months of tolerating the drug
Dose escalation is a common trigger.
In the case our physicians published, a patient moved through three months of dose increases from 2.5 mg up to 7.5 mg with no trouble at all, losing around 20 lbs along the way. After her first 10 mg dose she developed lip swelling and widespread hives over the following four days.
If symptoms start after a dose increase, the timing is worth reporting rather than waiting out.
What a tirzepatide reaction looks like
The reactions that need attention are:
Hives, meaning raised itchy welts that come and go, appearing anywhere on the body rather than only at the injection site.
Angioedema, meaning swelling of the lips, tongue, face or throat. Lip swelling is a common presentation.
Anaphylaxis, meaning throat tightness, difficulty breathing, wheezing, dizziness or collapse, usually alongside skin symptoms. Biphasic anaphylaxis to tirzepatide, where the reaction settles and then returns hours later, has been reported.
Injection site reactions, meaning redness and irritation confined to where the needle went in. These are local and usually resolve on their own.
If you have symptoms of anaphylaxis, use epinephrine and call 911. Epinephrine comes as an autoinjector (EpiPen, Auvi-Q) and as a nasal spray (neffy), and we compare the options here: Auvi-Q vs EpiPen.
Antihistamines have a role after epinephrine, since they help with the itching and hives driven by histamine. They are not a substitute for epinephrine and should not be relied on as the treatment for a serious reaction.
When steroids and antihistamines do not fix it
In the published case, the patient’s symptoms persisted through an intramuscular antihistamine, a five-day course of prednisone, two emergency department visits with intravenous steroids and an overnight observation. The swelling resolved only once tirzepatide was stopped.
Tirzepatide has a half-life of roughly five days and stays in the system for weeks after the last dose. While the drug is still circulating, treating the symptoms is working against a supply that keeps arriving.
If you are being treated for what looks like an allergic reaction and it is not improving, what is still in your system is a reasonable question to raise.
Why a negative prick test does not settle it
There are two kinds of allergy skin test, and they do not have the same sensitivity.
A prick test puts a tiny amount of the substance on the surface of the skin and pricks through it. It is quick and it is the usual starting point.
An intradermal test injects a very small, diluted amount just under the surface. It picks up reactions a prick test can miss.
Our patient had a prick test to tirzepatide and it came back negative. The test itself was working correctly, because the control substances behaved exactly as they should. The result was real.
She then had an intradermal test with the medication diluted to a tenth of its strength. That one was clearly positive, raising a welt about the size of a pencil eraser.
Had the workup stopped at the prick test, she would have been told her reaction was not an allergy.
If the story fits a drug reaction and the prick test is negative, the next step is to test further. If you have been told your reaction was not an allergy on the basis of a prick test alone, it may be worth another look.
Can you switch to a different GLP-1 medication?
Sometimes.
Reacting to tirzepatide does not automatically mean you will react to semaglutide. Tirzepatide acts on both the GIP and GLP-1 receptors while semaglutide acts on the GLP-1 receptor alone, and the two have different structures and different inactive ingredients.
In the published case, intradermal testing to semaglutide was negative in a patient who had tested positive to tirzepatide. She then had a supervised subcutaneous challenge with semaglutide 0.25 mg in the office, was monitored for an hour, had no reaction, and was cleared to start semaglutide under her endocrinologist. She has continued it without the reaction returning.
That is a single patient. There are no validated skin testing protocols published for this class of drug, and cross-reactivity within the class is still poorly understood. A reaction to one GLP-1 medication is a question worth testing rather than a settled answer about the whole class.
Testing first and challenging under supervision is where the value came from. Trying the switch at home is a different proposition entirely.
What an evaluation involves
History first. What happened, how long after the dose, how long it lasted, which product, what dose you were on and whether you had just escalated, what else you took, and whether it has happened more than once. Photographs help, so take them at the time.
Then testing. A prick test to the drug first, then an intradermal test if the prick comes back negative and your history still points at the medication. If the goal is to find something else you can take, we test the other drugs in the class at the same visit.
Bloodwork where it is needed, mainly to rule out the conditions that look like drug reactions without being one. Some forms of recurrent swelling are inherited or develop later in life and have nothing to do with any medication. These are checked for properly rather than assumed away.
A supervised challenge if testing suggests an alternative is tolerable. A small dose in the office with monitoring afterward.
Antihistamines interfere with skin testing and need to be stopped beforehand, though stopping them abruptly can cause symptoms to flare. Tell us what you are taking so we can plan the timing.
Our published case
Our physicians published this case in Clinical Case Reports in July 2026. It describes a patient with confirmed tirzepatide hypersensitivity who was tested, found not to react to semaglutide, challenged under supervision, and returned to treatment.
It reflects how we approach these reactions. The aim is to work out precisely what you reacted to and whether there is a route back to treatment that works for you.
Nejat C, Lin R, Addo D, Cuenca-Sisko K, Lee-Wong M. Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A Case Report. Clin Case Rep. 2026;14(7):e73183.
Frequently asked questions
Can you be allergic to Mounjaro or Zepbound? Yes. In placebo-controlled trials, hypersensitivity reactions were reported in 3.2% of Mounjaro-treated patients against 1.7% on placebo, and the label notes these are sometimes severe. Anaphylaxis has been described in published case reports.
What does a tirzepatide allergic reaction look like? Most often hives and swelling of the lips or face. More serious reactions involve throat tightness, difficulty breathing or dizziness and are a medical emergency.
Can a reaction start after months on the drug? Yes. Reactions have been described after months of tolerated treatment, often following a dose increase.
Why did my rash not respond to steroids? Tirzepatide has a half-life of about five days and stays in the body for weeks after the last dose. Symptoms often do not settle fully until the drug clears.
My prick test was negative. Does that rule out an allergy? No. An intradermal test, where a small diluted amount goes just under the skin, is more sensitive and has come back positive in patients whose prick test did not. If your history fits a drug reaction, a negative prick test is a reason to keep testing.
Can I switch to Ozempic or Wegovy if I reacted to Mounjaro? Possibly. Semaglutide is a different molecule and there is published evidence, including our own case, of patients tolerating it after a tirzepatide reaction. It should be confirmed with testing and a supervised challenge rather than attempted at home.
Is it the drug or something else in the injection? Either is possible. Reactions to inactive ingredients are recognized, which is one reason testing is worth doing rather than assuming the active drug is responsible.
Do I need to stop the medication before an appointment? Speak to your prescriber before stopping anything. If you have had a serious reaction the drug will usually already have been stopped. Do tell us what you are taking and when your last dose was.
Get it evaluated
If you have reacted to Mounjaro, Zepbound or another GLP-1 medication, our allergists can identify what you reacted to and whether there is a safe way to continue treatment. We see patients across our New York City and Long Island locations.
Call (212) 686-6321 to book an appointment.